The Chronic Plaque Psoriasis Market report provides an edge while developing business strategies, by understanding trends shaping and driving the global psoriasis market.
Psoriasis is recognized as the most prevalent immune-mediated inflammatory disease, involving skin and joints and associated with abnormalities of other systems. Even though the condition is not life-threatening, it is difficult to treat and response rates vary widely.
The key players of Chronic Plaque Psoriasis report are Amgen, Janssen, Abbvie, Novartis, AstraZeneca/Bausch Health, Eli Lilly, Sun Pharmaceutical, UCB Inc. LEO Pharma, and many others
Download free sample copy- https://www.delveinsight.com/sample-request/chronic-plaque-psoriasis-market
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Chronic Plaque Psoriasis Market: Treatment
Treatment modalities are chosen based on disease severity, relevant comorbidities, patient preference (including cost and convenience), efficacy, and evaluation of individual patient response. Although there is no cure for psoriasis, there are multiple effective treatment options, and topical therapy is the standard of care for treatment. Mild to moderate psoriasis can be treated topically with a combination of glucocorticoids, vitamin D analogues, and phototherapy. Systemic treatment, which includes immunosuppressants and biologics, are required in moderate-to-severe cases.
Chronic Plaque Psoriasis Market: Report
In recent years, several technologies have been developed to enhance the efficacy and safety of topical drug therapy. Furthermore, new drug carriers offer the opportunity to introduce new molecules into topical psoriasis therapy. For these purposes, vesicular drug delivery systems including niosomes, proniosomes, liposomes and transferosomes, nonvesicular drug delivery systems such as foams, gels, and nanoparticles have been developed.
Chronic Plaque Psoriasis Market: Insights
A range of agents is available for the symptomatic treatment of psoriasis. Patients with mild-to-moderate psoriasis usually receive topical treatments that modulate gene transcription, inhibit cell proliferation and promote keratinocyte differentiation. These cases can be treated topically with a combination of glucocorticoids, vitamin D analogues, and phototherapy.
Chronic Plaque Psoriasis Market: Outlook
Biologics have emerged as highly potent treatment options in patients for whom traditional systemic therapies fail to achieve an adequate response, are not tolerated owing to adverse effects, or are unsuitable owing to comorbidities.
Chronic Plaque Psoriasis Market: Forecast
Considered the cornerstone of topical treatment, corticosteroids are often well tolerated and effective for patients with mild psoriasis. Calcipotriol, a vitamin D3 analogue, is a first-line topical agent for the treatment of plaque psoriasis and moderately severe scalp psoriasis.
Following is the Table of Content of the report
1. Key Insights
2. Executive Summary of Chronic Plaque Psoriasis
3. Competitive Intelligence Analysis for Chronic Plaque Psoriasis
4. Chronic Plaque Psoriasis: Market Overview at a Glance
5. Chronic Plaque Psoriasis: Disease Background and Overview
6. Patient Journey
7. Chronic Plaque Psoriasis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Chronic Plaque Psoriasis Treatment
11. Marketed Products
13. Chronic Plaque Psoriasis: Seven Major Market Analysis
13.3. Chronic Plaque Psoriasis Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Chronic Plaque Psoriasis
17. KOL Views
18. Market Drivers
19. Market Barriers
21. DelveInsight Capabilities
23. About DelveInsight
Chronic Plaque Psoriasis Market: Report Scope
- The report covers the descriptive overview of Chronic Plaque Psoriasis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Chronic Plaque Psoriasis epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Chronic Plaque Psoriasis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Chronic Plaque Psoriasis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Chronic Plaque Psoriasis market
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving the Chronic Plaque Psoriasis market
- To understand the future market competition in the Chronic Plaque Psoriasis market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Chronic Plaque Psoriasis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Chronic Plaque Psoriasis market
- To understand the future market competition in the Chronic Plaque Psoriasis market
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States